Clonazepam Impurity 15 | CAS 191085-33-3 - Request Quote
Clonazepam Impurity 15
| SZ CAT No: | SZ-C079023 |
| CAS No | 191085-33-3 |
| Mol.F. | C30H21Cl2N5O8 |
| Mol.Wt. | 650.4 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Clonazepam Impurity 15 is chemically 2,2'-Azanediylbis(N-(2-(2-chlorobenzoyl)-4-nitrophenyl)acetamide). Clonazepam Impurity 15 is supplied with detailed characterization data compliant with regulatory guideline. Clonazepam Impurity 15 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Clonazepam.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 191085-33-3
Purchase 191085-33-3
Order 191085-33-3
Enquire 191085-33-3
price of 191085-33-3
191085-33-3 Supplier
191085-33-3 Manufacturer
191085-33-3 Exporter
buy high quality Clonazepam Impurity 15
Purchase Clonazepam Impurity 15
Clonazepam Impurity 15 suppliers
Clonazepam Impurity 15 manufacturers
Clonazepam Impurity 15 price
Order Clonazepam Impurity 15
Enquire Clonazepam Impurity 15
Clonazepam Impurity 15 cost
Clonazepam Impurity 15 Supplier
Clonazepam Impurity 15 Distributor
Clonazepam Impurity 15 for Method Validation
Clonazepam Reference Standard
Clonazepam Impurity 15 for ANDA Filing
Clonazepam Impurity 15 for Forced Degradation Studies
Clonazepam Impurity 15 Identification Standards
Clonazepam Impurity 15 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


